Raymond James & Associates’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $3.01M | Sell |
|
|||||
|
2024
Q2 | $3.95M | Buy |
|
|||||
|
2024
Q1 | $2.27M | Buy |
|
|||||
|
2023
Q4 | $2.73M | Buy |
|
|||||
|
2023
Q3 | $2.2M | Buy |
|
|||||
|
2023
Q2 | $2.24M | Buy |
|
|||||
|
2023
Q1 | $2.12M | Sell |
|
|||||
|
2022
Q4 | $2.64M | Buy |
|
|||||
|
2022
Q3 | $2.13M | Sell |
|
|||||
|
2022
Q2 | $2.35M | Sell |
|
|||||
|
2022
Q1 | $5.4M | Sell |
|
|||||
|
2021
Q4 | $7.38M | Buy |
|
|||||
|
2021
Q3 | $7.5M | Sell |
|
|||||
|
2021
Q2 | $6.75M | Buy |
|
|||||
|
2021
Q1 | $5.17M | Buy |
|
|||||
|
2020
Q4 | $4.41M | Buy |
|
|||||
|
2020
Q3 | $4.61M | Buy |
|
|||||
|
2020
Q2 | $4.54M | Buy |
|
|||||
|
2020
Q1 | $2.88M | Buy |
|
|||||
|
2019
Q4 | $226K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $222K | Buy |
|